SERUM ISOFORM [-2]PROPSA (P2PSA) AND ITS DERIVATIVES, NAMELY %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN MEN YOUNGER THAN 60 YEARS OF AGE FOR PREDICTION OF PROSTATE CANCER. RESULTS FROM A MULTICENTRIC EUROPEAN STUDY (PROMETHEUS PROJECT)